NVST vs TECH · P/E 56, rev $2.51B vs P/E 65, rev $1.22B
Envista Holdings Corp (NVST) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Envista Holdings Corp (NVST) is a medical instruments & supplies company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported NVST revenue for 2024-12-31 was $2.51B. Net income was -$1.12B. Revenue was down 2.2% from 2023-12-31 to 2024-12-31. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
NVST currently screens at market cap $3.72B and trailing P/E 55.8. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the NVST and TECH stock pages for the full models.
Not investment advice.